A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants
NCT06877624
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
QRL-101
Sponsor
QurAlis Corporation